XSHG
600278
Market cap830mUSD
Oct 09, Last price
6.62CNY
1D
2.48%
1Q
8.52%
Jan 2017
-59.44%
IPO
-40.41%
Name
Orient International Enterprise
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Orient International Enterprise, Ltd. engages in logistics business in China and internationally. The company imports and exports commodities for textile raw materials and textile products and mechanical and electrical products; and medical devices, including MRI, linac, CT imaging system, digital angiograph, biochemical analyzer, surgical instruments, and other medical equipment and instruments. It also provides warehousing, air freight, shipping and transportation, and international logistics services; and domestic trade in e-commerce, food, and light textile clothing products. In addition, the company imports and exports textile and garments comprising fabric, various home textiles, knitted wears, shirt, T-shirts, and jackets or men and women under the Kool, Rose, Milky Way, Sparrow333 and LEETAI brands; international procurement, tender, and import for medical equipment, IT products, and telecommunications products and equipment sets, as well as steel and iron, coal, wood, chemical raw materials, wool and cotton. The company was founded in 1998 and is based in Shanghai, China. Orient International Enterprise, Ltd. operates as a subsidiary of Orient International (Holding) Co., Ltd.
Key people
Jie Bian
Deputy General Manager · since 2011
Yiming Sheng
Deputy General Manager · since 2014
Qi Sun
Deputy General Manager · since 2011
Di Zhang
Deputy General Manager · since 2011
Fukang Xu
Deputy Chief Financial Officer · since 2011
Dayu Huang
Secretary of the Board
Shengjun Ji
Director · since 2011
Yongming Lu
Chairman of the Board · since 2013
Jia Wang
Director · since 2013
Weimin Zhong
Director · since 2011
Jun Zhou
Vice Chairman of the Board · since 2014
Yi Wei
Independent Director · since 2011
Lenian Xu
Independent Director · since 2011
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||